Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Catalani, Simona ^a   Carbonaro, Valentina ^a   Palma, Francesco ^a   Arshakyan, Marselina ^a   Galati, Rossella ^b   Nuvoli, Barbara ^b   Battistelli, Serafina ^a   Canestrari, Franco ^a   Benedetti, Serena ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; Cellfood ; Glucose transporter 1; Hypoxia inducible factor 1 alpha; Lactate dehydrogenase; Leukemic cells; Tumor metabolism

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CASPASE 3; CELLFOOD; DEUTERIUM; ENZYME; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MINERAL; NUTRACEUTICAL; SULFATE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRAIN U937; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA CLEAVAGE; DNA FRAGMENTATION; GLYCOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MITOCHONDRIAL RESPIRATION; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACIDS; APOPTOSIS; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; ENZYMES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JURKAT CELLS; K562 CELLS; LEUKEMIA; MINERALS; PLANT EXTRACTS; RHODOPHYTA; SULFATES; U937 CELLS;

EID: 84883688502     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-63     Document Type: Article

References (41)

1. Energy metabolism in tumor cells. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E, FEBS J 2007 274 1393 1418 10.1111/j.1742-4658.2007.05686.x 17302740
2. Regulation of cancer cell metabolism. Cairns RA, Harris IS, Mak TW, Nat Rev Cancer 2011 11 85 95 21258394
3. Cancer's molecular sweet tooth and the Warburg effect. Kim JW, Dang CV, Cancer Res 2006 66 8927 8930 10.1158/0008-5472.CAN-06-1501 16982728
4. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB, Cell Metab 2008 7 11 20 10.1016/j.cmet.2007.10.002 18177721
5. Cancer cell metabolism: Warburg and beyond. Hsu PP, Sabatini DM, Cell 2008 134 703 707 10.1016/j.cell.2008.08.021 18775299
6. Tumor suppressors and cell metabolism: a recipe for cancer growth. Jones RG, Thompson CB, Genes Dev 2009 23 537 548 10.1101/gad.1756509 19270154
7. HIF-1: upstream and downstream of cancer metabolism. Semenza GL, Curr Opin Genet Dev 2010 20 51 56 10.1016/j.gde.2009.10.009 19942427
8. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Semenza GL, Oncogene 2010 29 625 634 10.1038/onc.2009.441 19946328
9. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Denko NC, Nat Rev Cancer 2008 8 705 713 10.1038/nrc2468 19143055
10. Roles of p53, Myc and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Yeung S, Pan J, Lee MH, Cell Mol Life Sci 2008 65 3981 3999 10.1007/s00018-008-8224-x 18766298
11. Apoptosis: a review of programmed cell death. Elmore S, Toxicol Pathol 2007 35 495 516 10.1080/01926230701320337 17562483
12. Apoptosis in cancer: from pathogenesis to treatment. Wong RS, J Exp Clin Cancer Res 2011 26 30 87
13. Why do cancers have high aerobic glycolysis? Gatenby RA, Gillies RJ, Nat Rev Cancer 2004 4 891 899 10.1038/nrc1478 15516961
14. Targeting cancer metabolism. Teicher BA, Linehan WM, Helman LJ, Clin Cancer Res 2012 18 5537 5545 10.1158/1078-0432.CCR-12-2587 23071355
15. Metabolic modulation of glioblastoma with dichloroacetate. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC, Sci Transl Med 2010 2 31 34
16. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells. Xie J, Wang BS, Yu DH, Lu Q, Ma J, Qi H, Fang C, Chen HZ, Int J Oncol 2011 38 409 417 21132264
17. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation. Kumar A, Kant S, Singh SM, Chem Biol Interact 2012 199 29 37 10.1016/j.cbi.2012.06.005 22705712
18. Hypoxia, free radicals and antioxidants. The "Deutrosulfazyme" paradox. Iorio EL, Hypoxia Medical J 2006 32 1 2
19. Growth-inhibitory effects of a mineralized extract from the red marine algae, Lithothamnion calcareum, on Ca(2+)-sensitive and Ca(2+)-resistant human colon carcinoma cells. Aslam MN, Bhagavathula N, Paruchuri T, Hu X, Chakrabarty S, Varani J, Cancer Lett 2009 283 186 192 10.1016/j.canlet.2009.03.037 19394137
20. A multi-mineral natural product inhibits liver tumor formation in C57BL/6 mice. Aslam MN, Bergin I, Naik M, Hampton A, Allen R, Kunkel SL, Rush H, Varani J, Biol Trace Elem Res 2012 147 267 274 10.1007/s12011-011-9316-2 22222483
21. The antioxidant protection of CELLFOOD against oxidative damage in vitro. Benedetti S, Catalani S, Palma F, Canestrari F, Food Chem Toxicol 2011 49 2292 2298 10.1016/j.fct.2011.06.029 21703326
22. Cellfood™ improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced reactive oxygen species (ROS) generation. Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME, J Physiol Pharmacol 2011 62 287 293 21893688
23. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Vander Heiden MG, Cantley LC, Thompson CB, Science 2009 324 1029 1033 10.1126/science.1160809 19460998
24. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
25. A simple salting out procedure for extracting DNA from human nucleated cells. Miller SA, Dykes DD, Polesky HF, Nucleic Acids Res 1988 16 1215 10.1093/nar/16.3.1215 3344216
26. Energy metabolism in H460 lung cancer cells: effect of histone deacetylase inhibitors. Amoêdo ND, Rodrigues MF, Pezzuto P, Galina A, da Costa RM, de Almeida FC, El-Bacha T, Rumjanek FD, PLoS ONE 2011 6 22264 10.1371/journal.pone.0022264 21789245
27. Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. Comin-Anduix B, Boros LG, Marin S, Boren J, Callol-Massot C, Centelles JJ, Torres JL, Agell N, Bassilian S, Cascante M, J Biol Chem 2002 277 46408 46414 10.1074/jbc.M206150200 12351627
28. Models for prevention and treatment of cancer: problems vs promises. Aggarwal BB, Danda D, Gupta S, Gehlot P, Biochem Pharmacol 2009 78 1083 1094 10.1016/j.bcp.2009.05.027 19481061
29. Targeting Cell Signaling and Apoptotic Pathways by Dietary Agents: Role in the Prevention and Treatment of Cancer. Shanmugam MK, Kannaiyan R, Sethi G, Nutr Cancer 2011 63 161 173 10.1080/01635581.2011.523502 21294053
30. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP, Wang LY, Wu JB, Xing CY, Yu K, J Exp Clin Cancer Res 2012 27 31
31. Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, Chen Y, J Exp Clin Cancer Res 2012 31 48 10.1186/1756-9966-31-48 22607709
32. Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation. Krifa M, Alhosin M, Muller CD, Gies JP, Chekir-Ghedira L, Ghedira K, Mély Y, Bronner C, Mousli M, J Exp Clin Cancer Res 2013 32 30 10.1186/1756-9966-32-30 23688286
33. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A, J Exp Clin Cancer Res 2013 32 1 57 10.1186/1756-9966-32-57 23958461
34. Etoposide, topoisomerase II and cancer. Baldwin EL, Osheroff N, Curr Med Chem Anticancer Agents 2005 5 363 372 10.2174/1568011054222364 16101488
35. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Zheng J, Oncology Letters 2012 4 1151 1157 23226794
36. Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation. Lunt SY, Vander Heiden MG, Annu Rev Cell Dev Biol 2011 27 441 464 10.1146/annurev-cellbio-092910-154237 21985671
37. Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. Rastogi S, Banerjee S, Chellappan S, Simon GR, Cancer Lett 2007 257 244 251 10.1016/j.canlet.2007.07.021 17910902
38. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Icard P, Lincet H, Biochim Biophys Acta 1826 2012 423 433
39. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Fantin VR, St-Pierre J, Leder P, Cancer Cell 2006 9 425 434 10.1016/j.ccr.2006.04.023 16766262
40. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV, PNAS 2010 107 2037 2042 10.1073/pnas.0914433107 20133848
41. The metabolic advantage of tumor cells. Israël M, Schwartz L, Mol Cancer 2011 10 70 10.1186/1476-4598-10-70 21649891